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doi:10.1016/j.ejvs.2010.11.002Abstract Introduction: Indication to carotid revascularisation is commonly determined by
percent of stenosis as well as neurological symptoms and clinical conditions. High plaque
embolic potential is defined as ‘vulnerability’; however, its characterisation is not universally
used for carotid revascularisation. We investigated the role of contrast-enhanced ultrasonog-
raphy (CEUS) to identify carotid vulnerable plaque.
Methods: Patients undergoing carotid endarterectomy were preoperatively evaluated by cere-
bral computed tomography (CT) scan and CEUS. Contrast microbubbles detected within the
plaque indicated neovascularisation and were quantified by decibel enhancement (dB-E). Pla-
ques were histologically evaluated for five features: (microvessel density, fibrous cap thick-
ness, extension of calcification, inflammatory infiltrate and lipid core) and blindly scored
1e5 to assess plaque vulnerability. Analysis of variance (ANOVA), Fisher’s and Student’s t-test
were used to correlate patients’ characteristics, histological features and dB-E.
Results: In 22 patients, dB-E (range 2e7.8, mean 4.85  1.9 SD) was significantly greater in
symptomatic (7.40  0.5) vs. asymptomatic (3.5  1.4) patients (p Z 0.002). A higher dB-E
was significantly associated with thinner fibrous cap (<200 mm, 5.96  1.5 vs. 3  1,
pZ 0.01) and greater inflammatory infiltrate (3.2  0.9 vs. 6.4  1.2, pZ 0.03). Plaques with
vulnerability score of 5 had significantly higher dB-E compared with those with vulnerability51 6364244; fax: þ39 051 6363288.
unibo.it (G.L. Faggioli).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Contrast Ultrasonography and Carotid “Vulnerable Plaque” 239score of 1 (7.6  0.2 vs. 2.5  0.6, respectively, p Z 0.001). Preoperative ipsilateral embolic
lesions at CT were correlated with higher dB-E (5.96  1.5 vs. 3.0  1.0, p Z 0.01).
Conclusion: CEUS with dB-E is indicative of the extent of plaque neovascularisation. It can be
used therefore as a marker for vulnerable plaque.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Carotid artery stenosis is one of the leading causes of stroke
and the benefit of carotid surgical revascularisation in both
symptomatic and asymptomatic patients has been shown
by a number of trials.14 The percent of carotid stenosis is
presently the main parameter in the indication to revas-
cularisation; however, other plaque characteristics, namely
its composition and morphology, could play a significant
role in the development of stroke, and should therefore be
considered in the decision-making process.5
Neurological symptoms are associated with a number of
histological patterns, such as higher immature microvessel
density, subsequent intraplaque haemorrhage and fibrous
cap rupture.68 Angiogenesis is also related to an increased
inflammatory infiltrate and plaque instability.9,10 Thus,
plaque characterisation could be an important adjunct for
stroke risk stratification in patients with asymptomatic
carotid artery stenosis.
Carotid contrast-enhanced ultrasonography (CEUS), a rela-
tively new technique for the evaluation of plaque structure,
allows detection of the plaque microvessels to identify the
carotid ‘vulnerable plaque’, associated with high embolic
potential.1113 As this field has been scarcely investigated in
the literature,weperformeda study to correlateCEUSfindings
with neurological symptoms, cerebral ischaemic lesions and
plaquehistology to identify the ‘vulnerableplaque’, namely its
embolic potential.
Materials and Methods
Patients
A series of consecutive patients with either symptomatic or
asymptomatic carotid artery stenosis 70% were submitted
to carotid endarterectomy (CEA), according to ESVS and
Society of Vascular Surgeons (SVS) recommendations. Symp-
tomatic carotid stenosis, defined as ipsilateral cerebral
ischaemic events (major or minor stroke or transient
ischaemic attack (TIA) or amaurosis fugax) that occurred in
the last 6months, were evaluated by independent in-hospital
neurologists.14,15 Epidemiological data, neurological symp-
toms, vascular risk factors (hypertension, coronary-artery
disease, chronic-obstructive pulmonary disease, dyslipidae-
mia, diabetes mellitus, current smoking and chronic-renal
failure) and current therapy (acetylsalicylic acid (ASA),
anticoagulant and hydroxymethyl glutaryl coenzyme A
reductase inhibitor) were recorded in a database software.
Emergency procedures for acute ischaemic symptoms were
not included in the study.
Preoperative cerebral computed tomography (CT) scan
was performed in all cases to identify possible ischaemic
lesions. CEUS plaque evaluation was performed in the daysimmediately before surgery. All patients gave their informed
consent for the study before CEA, which was performed in
a standard fashion through a laterocervical approach.
CT scan
Cerebral CT was performed in all patients using a multi-
slice (16-slice) GE Light Speed scanner (General Electric,
Milwaukee, WI, USA). According to Mofidi et al.,16 the
presence of cerebral ischaemic lesion ipsilateral to the side
of the carotid plaque was considered a positive CT evalu-
ation. Cerebral ischaemic lesions were defined as areas of
low attenuation, involving both grey and white matter or
focal areas of encephalomalacia. Cerebral CT evaluation
was performed blindly by two different operators within 2
weeks before surgery.
CEUS
Carotid ultrasonography was performed with an ultrasound
machine (Philips IU22, Amsterdam, the Netherlands) by
a blinded expert operator (with more than 100 carotid
ultrasound examinations performed per year), within 2weeks
before surgery. A contrast-specific software operating at low
mechanical index was used. The power modulation mode
(IU22)was used. The second-generation echo-contrast agent,
SonoVue (Bracco, Milan, Italy), was employed. SonoVue is
based on microbubbles stabilised by phospholipids and filled
with sulphur hexafluoride with a median diameter of 2.5 mm.
The low solubility and the high resistance of the shell to the
mechanical effect of the ultrasound (US) beam allow this
contrast agent to act for a long period of time (10 min). The
contrast solution is prepared immediately before adminis-
tration by adding 5 ml of sterile saline solution (0.9% NaCl) to
the vial and by vigorously shaking it for at least 20 s. SonoVue
was administered as a bolus at a dose of 5ml andwas injected
intravenously through a 20-gauge intravenous catheter, fol-
lowed by a 10-ml-flush of saline water (0.9% NaCl). A linear
probe with a transmission frequency of 10e12 MHz was used
by a blinded expert operator. Common, internal and external
carotid arteries were visualised in the longitudinal and the
transverse planes. Images of plaques in B, Colour and Power
modes were digitally stored. CEUS evaluation was performed
as follows. After presetting real-time, contrast-enhanced
imaging modality with coded pulse-inversion technique,
image settings were adjusted for maximising the contrast
signal. The mechanical index was preset to 0.13 and the
frame rate to 12 per s, to reduce microbubble destruction,
with image depth at 3e5 cm, according to the patients’
anatomical necks characteristics. The longitudinal carotid
plaques images in real-time visualisationwith the presence of
microbubbles in carotid lumen and in the plaques’ micro-
vessels were digitally stored for later outline-blinded soft-
ware analysis. Image storing was performed for at least
Figure 1 Image sequences of carotid plaque before (A) and after (B) CEUS microvessel detection. Panel B shows the area within
the plaque filled with neovessels (red arrows). In panel A, only the border of the plaque is visible (black arrows) showing two ulcers.
240 G.L. Faggioli et al.10 min, from the moment of injection to the time of
decreasing microbubbles concentration in carotid lumen.
QLab (Philips Healthcare, India) software was used for the
outline plaques vascularisation analysis, obtaining the
maximum level of dB-Enhanced (dB-E) at the peak of micro-
bubbles’ concentration for each plaque analysed. The stored
images sequences were evaluated identifying the carotid
plaque, delineating the region of interest and eventually
performing the software analysis of microbubbles concen-
tration within the plaques and recording dB-E values (Fig. 1).
Histological analysis
Carotid plaques were removed in full during surgery to
preserve the plaque structure. After 24 h of decalcification,
samples were cut in serial sections and the area with the
highest percentage of stenosis was identified and defined
as the area of interest for further analysis. Plaque tissue
samples were fixed in formalin buffered 10% and embedded
in paraffin; 5-mm-thick haematoxylin and eosin-stained
sections were observed under a light microscope (LM,
Olympus CX42). Carotid atherosclerotic lesions were defined
according to the American Heart Association (AHA) classifi-
cation,17 and grouped as type IeVI ranging from the initial
lesion to the complicated lesion. An experienced pathologist
performed all histopathological analysis.Table 1 Histological considerations to evaluate the vulnerabili
Histological features Parameters
Calcification extension Sections
Lipid core extension Sections
Thin fibrous cap Sections
Inflammation score
CD68 0 to 3þ
CD3 0 to 3þ
Tryptase 0 to 3þ
Neoangiogenesis CD34 Microvessel densityVulnerability
Based on histological studies of culprit plaques, vulnerable
plaques are generally felt to have three histologic hall-
marks compared with stable plaques1821: a larger lipid
core (>40% of total lesion area), a thinner fibrous cap and
many inflammatory cells. In addition to the above triad,
previous studies have noted two other morphological
features that define a vulnerable plaque: calcified lesions22
and neoangiogenesis.23
We define vulnerability of the plaque following these
last assumptions. Extension of calcification and the lipid
core was evaluated on entire circumferential arterial
sections dividing the field into four equal parts. The
extension was scored in numerical values ranging from 0 to
4 (0 Z no calcification or core at all, 1 Z 1/4, 2 Z 2/4,
3Z 3/4 and 4Z 4/4). Fibrous cap thickness was measured
with a score of 0 (>200 mm) or 1 (<200 mm), and by eval-
uating intraplaque haemorrhage with a value of 0 if absent
or 1 if present. Cellular inflammation infiltrate was char-
acterised with the following immunohistochemical
markers: CD68 as a macrophage marker, Tryptase (serine
proteinase stored in the mast cell secretory granules) as
a mast cell marker and CD3 as a lymphocyte marker.
Microvessel density count was obtained with CD34 as
a marker of immature and mature endothelial cells (Ecs).
Table 1 summarises this histological features in scorety of the carotid plaque.
Evaluation Score
2/4 0
>2/4 1
2/4 0
>2/4 1
200 mm 0
>200 mm 1
Score of the markers
<4þ 0
4þ 1
<50 mm2 0
50 mm2 1
Table 3 Comparative evaluation of plaque dB-Enhance-
ment and patient characteristics.
N (%) dB-E p value
Age
>80 years 4 (18) 4.0  2.0 0.38
<80 years 18 (82) 5.5  2.1
Gender
Male 15 (68) 4.5  2.2 0.67
Female 7 (32) 3.7  1.7
Neurological symptoms
Yes 7 (32) 7.4  0.5 0.006
No 15 (68) 3.5  1.4
Dislipidemia
Yes 13 (59) 4.2  0.5 1.00
No 9 (4) 4.2  2.5
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muscle actin (alpha-SMA) antibody was used to provide
a general view of the plaque architecture.
Immunohistochemical assay
The carotid samples were immediately fixed in 10% neutral,
buffered, pH-6.9 formalin. Macrophotographs of the sections
in its integrity were taken. Formalin-fixed paraffin embedded
5-mm-thick tissue carotid sections were dewaxed and rehy-
drated through graded steps of ethanol absolute (Xilol 30 min,
100% 10 min, 95% 5 min, 70% 5 min). Antigen retrieval
was performed with a heat-mediatedmethod at 1 atm, 120 C
for 20 min in a citrate buffer solution (pH 6) and cooling for
20 min. Endogenous peroxidase activity was blocked with 3%
H2O2 in absolutemethanol for 10minat roomtemperature (rt),
in the dark. Antigeneantibody reaction was developed with
the NovoLink Polymer Detection Kit (Novocastra, Newcastle,
UK). Sections were incubated overnight in a wet chamber at
4 C with monoclonal antibodies against CD3 (1:100, rabbit
monoclonal antibody, SP7 clone, Neomarker, Fremont,
CA, USA), CD68 (1:200, monoclonal mouse anti-human, PG-M1
clone; Dako A/S, Copenhagen, Denmark), Tryptase (1:50,
monoclonal mouse anti-human mast cell tryptase, AA1 clone;
Dako A/S, Copenhagen, Denmark), CD34 (1:80, monoclonal
mouse anti-human, Q-BEnd-10 clone; Dako A/S, Copenhagen,
Denmark) and ACML (1:9000, monoclonal anti-alpha smooth
muscle actin, 1A4 clone, Sigma, Saint Louis, Missouri, USA);
then, sections were incubated with NovoLink Polymer
for 30 min at rt, and subsequently with diaminobenzidine
(NovoLink DAB Substrate Buffer) for 1 min. Cell nuclei were
stained with Mayer’s haematoxylin (Sigma Chemicals). Nega-
tive controls were done without the primary antibody against
CD3, CD68, Tryptase, CD34 or ACML. Finally, samples were
dehydrated with graded steps of ethanol absolute andTable2 Epidemiology and preoperative clinical characteristics.
Mean  SD
Age, years 72.3  8.5
N %
Male gender 15 68
Neurological symptoms 7 32
Transient ischaemic attack 4 18
Stroke 3 14
Ischaemic lesion at CT ipsilateral
to carotid stenosis
9 41
Hypertension 21 95
Dislipidemia 9 41
Diabetes 8 36
Smoke 5 23
Chronic-obstructive pulmonary disease 7 32
Chronic-renal failure (GFR < 60 ml/min) 5 23
Coronary-artery disease 6 27
ASA 22 100
Anticoagulant 0 0
Hydroxymethyl glutaryl coenzyme
A reductase inhibitor user
10 46
CT: computed tomography; ASA: acetylsalicylic acid; GFR:
glomerular filtration rate.mountedontoglass slidesusingCanadaBalsam(SigmaeAldrich
C1795). The sections were observed under a light microscope
(Leitz Wetzlak, Germany 12 V max, 100W) connected with
a charge-coupled device (CCD) camera Olympus CX42. Images
were acquired using Image-Pro Plus software (Media Cyber-
netics http://www.mediacy.com) and processed with ImageJ
free software (http://rsbweb.nih.gov/ij/).
Inflammatory infiltrate evaluation
An average of 5 fields per plaque transverse section was
evaluated for each section; the area evaluated for each
imagewas 0.12mm2 at amagnification of 10. The positivity
for each antibody was arbitrarily semiquantitatively scored
as intense (3þ), moderate (2þ), low (1þ) or absent (0). To
quantify the inflammation infiltrate, we summed the scoreDiabetes
Yes 8 (36) 3.6  1.1 1.00
No 14 (64) 4.8  2.5
Smoke
Yes 5 (23) 4.0  1.4 0.83
No 17 (77) 4.1  2.1
Chronic-obstructive pulmonary disease
Yes 7 (32) 4.3  2.5 1.00
No 15 (68) 4.2  2.0
Chronic-renal failure (GFR < 60 ml/min)
Yes 3 (14) 3.0  1.4 0.34
No 19 (86) 4.5  2.0
Coronary-artery disease
Yes 6 (28) 3.5  0.7 0.67
No 16 (72) 4.4  2.2
Hydroxymethyl glutaryl coenzyme A reductase
inhibitor user
Yes 10 (46) 3.6  1.0 0.34
No 12 (54) 4.9  2.7
dB-E: dB-Enhancement; GFR: glomerular filtration rate.
Table 4 Evaluation of clinical and histological characteristics and dB-Enhancement in asymptomatic and symptomatic patients.
Asymptomatic patients Symptomatic patients
N (%) dB-E p value N (%) dB-E p value
Epidemiology
Age
>80 years 2 (13) 4.0  1.1 0.76 2 (29) 6.8  0.6 0.4
<80 years 13 (87) 3.5  1.5 5 (71) 7.5  0.6
Gender
Male 9 (60) 4.2  0.5 0.74 6 (86) 7.3  0.5 e
Female 6 (40) 3.7  1.7 1 (14) 7.4
Dislipidemia
Yes 8 (53) 4.2  0.5 0.28 1 (14) 7.0 e
No 7 (47) 3.0  1.7 6 (86) 7.3  0.6
Diabetes
Yes 7 (47) 3.5  1.9 1.0 1 (14) 7.0 e
No 8 (53) 3.7  1.5 6 (86) 7.3  0.6
Smoke
Yes 3 (20) 4.0  1.4 0.83 2 (29) 6.9  0.5 0.52
No 12 (80) 3.4  1.5 5 (71) 7.5  0.4
Chronic-obstructive pulmonary disease
Yes 5 (33) 3.7  1.4 0.71 2 (29) 6.9  0.5 0.73
No 10 (67) 3.0  1.5 5 (71) 7.5  0.4
Chronic-renal failure (GFR <60 ml/min)
Yes 3 (20) 3.0  1.4 0.56 2 (29) 7.1  0.5 1.0
No 12 (80) 3.7  1.5 5 (71) 7.3  0.4
Coronary-artery disease
Yes 3 (20) 3.5  0.7 0.95 3 (43) 7.4  0.2 1.0
No 12 (80) 3.5  1.6 4 (57) 7.3  0.3
Hydroxymethyl glutaryl coenzyme A reductase inhibitor user
Yes 7 (47) 3.6  1.2 0.76 3 (43) 6.9  0.6 0.51
No 8 (53) 3.3  2.0 4 (57) 7.2  0.5
CT ischaemic lesion ipsilateral to carotid stenosis
Yes 3 (20) 4.5  0.7 0.31 3 (43) 7.2  0.3 0.85
No 12 (80) 3.3  1.5 4 (57) 7.4  0.7
Histology
Vessel density
< 50/mm2 12 (80) 3.0  0.7 0.30 1 (14) 6.8 e
 50/mm2 3 (20) 4.0  1.5 6 (86) 7.4  0.6
% of area occupied
<5 by vessels 11 (73) 4.1  0.9 1.0 2 (29) 7.2  0.5 0.58
5 by vessels 4 (27) 4.2  1.8 5 (71) 7.4  0.5
Vessels diameter
<5 mm 13 (87) 3.8  2.0 0.42 2 (29) 7.2  0.5 0.58
5 mm 2 (13) 4.5  1.1 5 (71) 7.4  0.5
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Table 4 (continued )
Asymptomatic patients Symptomatic patients
N (%) dB-E p value N (%) dB-E p value
Extension of calcification
III 1 (6) 3.8  1.0 0.75 1 (14) 7.6 e
II 6 (40) 3.5  2.8 4 (57) 7.1  0.5
I 6 (40) 4.0  0.9 2 (29) 7.3  0.5
0 2 (13) 4.0  0.8 2 (29)
e
6.8  0.6
Extension of the lipid core
III 3 (20) 4.5  0.7 0.60 1 (14) 7.5 e
II 8 (53) 4.0  2.0 4 (57) 7.3  0.6
I 4 (27) 3.9  0.7 2 (29) 7.4  0.5
Fibrous cap
<200 mm 8 (53) 4.9  1.0 0.09 5 (71) 7.3  0.4 1.0
200 mm 7 (47) 3.1  1.1 2 (29) 7.1  0.5
Intraplaque haemorrhage
Yes 5 (33) 4.5  0.8 0.56 4 (57) 7.2  0.3 0.85
No 10 (67) 3.6  1.5 3 (43) 7.4  0.7
Inflammatory infiltrate
Yes 4 (27) 5.4  1.2 0.10 6 (85) 7.4  0.6 e
No 11 (73) 3.2  1.8 1 (15) 6.8
Contrast Ultrasonography and Carotid “Vulnerable Plaque” 243positivity for CD3, CD68 and Tryptase. For a sample with an
inflammation score lower than 4þ and higher than or equal to
4þ, we attributed, respectively, a value of 0 (low) or 1 (high)
inflammatory infiltrate.
Neoangiogenesis evaluation
Neoangiogenesis was expressed as microvessel density,
identified by CD34-positive immunostaining. The 5 images
were converted to stack, transformed in montage, con-
verted from colour images to 8-bit greyscale and scale was
set (1600 px mm1). The total area in square millimetre was
evaluated for each stack, and then we set the lower and
upper threshold values to select the stained area for CD34.
For each stack, we count the total number of microvessels,
their diameter and the percentage of area occupied by
vessels for each photograph. The mean microvessels
density per section was expressed as a function of the total
area analysed in the 5 photographs (number of microvessels
per mm2).
Statistical analysis
Continuous data are expressed as mean standard deviation
(SD), and categorical variables by relative and absolute
frequencies. Analysis of differences between groups was
performed with Fisher’s exact test for categorical variables
and with unpaired Student’s t-test for continuous variables.
To compare continuous variables in more than two groups,
one-way analysis of variance (ANOVA) with posthoc test
analysiswas performed. The value ofp< 0.05was considered
significant. Statistical tests were performed using StatisticalPackage for Social Sciences (SPSS 13.0) for Windows
computer software (SPSS, Chicago, IL, USA).
Results
Patients’ characteristics and CEUS
From September 2009 to January 2010, 22 consecutive
patients were included into the study. Patients’ demographic
characteristics, vascular risk factors, clinical presentations
and current therapy are summarised in Table 2. All the 22
patients underwent CT scan and CEUS evaluation within 2
weeks prior to surgery. CEAs were achieved with no compli-
cations (death, stroke, TIA, myocardial infarction or cranial
nerve injury), and all carotid specimens were suitable for
histology and immunohistochemical analysis. No patient was
excluded from the study due to technical difficulties in CEUS
performance, sample plaque processing or other kinds of
complications.
The comparative evaluation of plaque through dB-E and
patients’ demographic characteristics, current therapy,
vascular risk factors and clinical presentations are reported
in Table 3. No statistically significant differences were
identified for demographic characteristics, vascular risk
factors or current therapy. As shown in Table 3, patients with
ischaemic neurological symptoms (stroke, TIA or amaurosis
fugax) had significant higher carotid dB-E compared with
asymptomatic ones (7.40  0.5 dB-E vs. 3.5  1.4 dB-E,
respectively, pZ 0.006). In asymptomatic and symptomatic
patients, there was no significant correlation between single
characteristics and dB-E values, as detailed in Table 4.
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The cerebral CT scan evaluation revealed the presence of
at least one focal low attenuation in 9 (41%) patients. There
were five (55%) patients with a single capsular ipsilateral
lesion, two (22.5%) patients with bilateral multiple areas of
low attenuation indicative of many ischaemic lesions and
two (22.5%) patients with an encephalomalacic lesion. The
evaluation of clinical characteristics differences between
positive cerebral CT scan patients and negative ones are
reported in Table 5; the presence of an ipsilateral embolic
lesion on preoperative CT scans was significantly correlatedTable 5 Comparative evaluation of clinical characteristics betw
Total patients (%) Positive cereb
Age 73.4  10.1
Gender
Male 15 (68) 7 (32)
Female 7 (32) 2 (9)
Neurological symptoms
Symptomatic 7 (32) 6 (27)
Asymptomatic 15 (68) 3 (14)
Dislipidemia
Yes 13 (59) 6 (27)
No 9 (41) 3 (14)
Diabetes
Yes 8 (36) 4 (18)
No 14 (64) 5 (23)
Smoke
Yes 5 (23) 3 (14)
No 17 (77) 6 (27)
Chronic-obstructive pulmonary disease
Yes 7 (32) 2 (9)
No 15 (68) 7 (32)
Chronic-renal failure (GFR < 60 ml/min)
Yes 3 (14) 1 (5)
No 19 (86) 8 (41)
Coronary-artery disease
Yes 6 (28) 3 (14)
No 16 (72) 6 (27)
ASA
Yes 10 (46) 5 (23)
No 12 (54) 4 (27)
Hydroxymethyl glutaryl coenzyme A reductase inhibitor user
Yes 10 (46) 5 (23)
No 12 (54) 4 (23)
dB-E 5.96  1.5
GFR: glomerular filtration rate; ASA: acetylsalicylic acid. The presen
plaque was considered a positive CT evaluation.with higher dB-E on CEUS compared with patients with
negative cerebral CT scan (5.96  1.5 dB-E vs. 3.0  1.0 dB-
E, respectively, p Z 0.01).
Histology and immunohistochemical assay and CEUS
The extension of calcification was stratified histologically
in five classes: class IV in none, III in two (9%) cases, II in
10 (46%) cases, I in 8 (36%) cases and 0 in 2 (9%) cases.
Extension of the lipid core was scored as class IV in no case,
III in four (18%) cases, II in 12 (54%) cases, I in 6 (27%) cases
and 0 in NOE case. The presence of fibrous cap <200 mmeen patients with positive and negative cerebral CT scan.
ral CT (%) Negative cerebral CT (%) p value
71.7  7.0 0.65
8 (36) 0.64
5 (23)
1 (5) 0.007
12 (54)
7 (32) 0.63
6 (27)
4 (18) 0.60
9 (41)
2 (9) 0.60
11 (50)
5 (23) 0.60
8 (36)
2 (9) 1.0
11 (45)
3 (14) 0.65
10 (45)
5 (23) 0.67
8 (27)
5 (23) 0.67
8 (31)
3.0  1.0 0.01
ce of cerebral ischaemic lesion ipsilateral to the side of carotid
Table 7 Comparative evaluation of histological carotid
plaques vascularisation elements and dB-Enhancement
levels (dB-E).
Plaques vascularisation N (%) dB-E p value
Vessel density
<50/mm2 13 (59) 2.5  0.7 0.04
50/mm2 9 (41) 5.5  1.2
% of area occupied
< 5 13 (59) 4.3  1.5 0.85
 5 9 (41) 4.6  2.5
Vessels diameter
<5 mm 15 (68) 4.2  2.2 0.69
5 mm 7 (32) 5.0  1.4
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intraplaque haemorrhage in 9 (41%) specimens. The corre-
lation between histological findings and the levels of dB-E
at CEUS investigation is reported in Table 6. According to
the AHA classification, 5 (23%) specimens were classified
5a, 5 (23%) class 5b and 12 (55%) class 6; no significant
differences were identified between AHA class plaques and
clinical and CEUS characteristics.
The immunohistochemical analysis showed the presence
of inflammation infiltrate in 10 (45%) specimens. The pres-
ence of inflammation infiltrate in the carotid plaque speci-
mens was related to higher dB-E at CEUS evaluation,
comparedwith specimenswithno inflammation (7.4 1.2 dB-
E vs. 3.2  0.9 dB-E, respectively, pZ 0.03).
The neovascularisation examination identified a vessel
density of 57.2  70.0 nm m2; the mean area occupied by
the vessel lumen was 6.2  6.7%. The majority of neo-
vessels identified had a mean diameter of 25 mm (80.4% of
vessels); in five cases, the vessels reached a diameter of
660 mm. The presence of elevated vessel density (50 mm2)
was identified in nine (41%) specimens; a high percentage
of area was occupied (5%) by neovessels in nine (41%)
cases. Table 7 reports the comparative evaluation of
histological plaques’ vascularisation and dB-E values at
CEUS investigation.
The immunohistochemical analysis also revealed different
patterns ofCD34 staining.Microvesselmorphology ranged from
small regular vessel, flattened, irregular lobulate-shaped
vessel or big angiomatoid vessel (Fig. 3). Microvessels were
identified in the medial border of the lipid core, within the
cap, within the lipid core, within the intima and in shoulder.Table 6 Comparative evaluation of plaque characteristics
and dB-Enhancement levels.
Plaque characteristics N (%) dB-E p value
Extension of calcification
IV 0 (0) 0.54
III 2 (9) 4.5  1.8
II 10 (46) 4.0  2.8
I 8 (36) 4.7  1.7
0 2 (9) 7.8  1.1
Extension of the lipid core
IV 0 (0) 0.52
III 4 (18) 3.0  1.1
II 12 (54) 5.3  2.3
I 6 (27) 4.7  0.3
0 0 (0)
Fibrous cap
<200 mm 13 (59) 5.96  1.5 0.01
200 mm 9 (41) 3.0  1.0
Intraplaque haemorrhage
Yes 9 (41) 3.5  2.9 0.36
No 13 (59) 4.7  0.9
Inflammation infiltrate
Yes 10 (45) 7.4  1.2 0.03
No 12 (55) 3.2  0.9The percentage of number of vessels per region was 59% in the
shoulder, 26% in the cap and 15% in the core.
The carotid vulnerability scored 1 in 6 (27%) patients
with dB-E 2.5  0.6; scored 2 in 10 (45%) patients with dB-E
4.6  0.8; scored 3 in none; scored 4 in 3 (14%) with dB-E
7.1  0.5 and scored 5 in three (14%) with dB-E 7.6  0.2.
The dB-E levels were significantly different between groups
(p Z 0.001) as shown in Fig. 2 and Table 8.
Discussion
With this study, we have observed a direct correlation
between CEUS characteristics of the carotid plaque and
cerebral symptoms. Histological indicators of plaque
vulnerability such as elevated number of microvessels, high
vessel total area, thin fibrous cap and inflammatory infil-
trate are associated with higher levels of dB-E at CEUS.
Similarly, clinical symptoms and CT scan signs of cerebral
infarction are correlated with higher levels of dB-E at CEUS
evaluation. Specifically, patients with positive cerebral CT
scan had significantly higher plaque dB-E than patients with
negative CT; thus, CEUS may help in the identification of
plaques with higher embolic potential. Few data have been
published in the literature so far in this regard.
The relationship between histological aspects of carotid
plaque vascularisation and cerebral symptoms has been
previously described by McCarty et al.,7 who identified
a higher number of microvessels in symptomatic plaques.
Dunmore et al.6 similarly showed this correspondence and
identified a relationship between cerebral symptoms and
the carotid plaque vessel morphology; irregular dysmorphic
vessels were found almost exclusively in plaques from
symptomatic patients. Others have observed a significantly
higher microvessel counts in patients with CT evidence of
ipsilateral cerebral infarction.16 While all these authors
confirm the role of carotid plaque histological features in
association with plaque’s vulnerability and in the develop-
ment of cerebral ischaemic events, the role of CEUS in the
identification of carotid plaque vascularisation has been
only partially investigated. Coli et al.24 and Saha et al.11
compared semiquantitatively CEUS with histological char-
acteristics. Their findings revealed that contrast enhance-
ment within the plaque is correlated with higher number of
Figure 2 dB-Enhancement evaluation of plaque vulnerability score. Differences between groups are statistically significant at
ANOVA analysis (p Z 0.001).
246 G.L. Faggioli et al.microvessels, similar to the results of other studies.25,26
Symptomatic patients had higher contrast enhancement in
CEUS evaluation in other studies.25,26 Therefore, CEUS has
been proposed as a method to identify preoperatively
vulnerable plaques. With the present study, we were able
to combine all those previous findings with CT results, thus
defining the strict correlation among CEUS appearance,
histological features and clinical significance. Moreover, an
objective and reproducible CEUS measurement was adop-
ted. In this sense, CEUS could be helpful in identifying
asymptomatic plaque with higher embolic potential.
The present study reveals that plaques with elevated
number of microvessels and high vessel total area show
a significantly higher contrast enhancement at CEUS soft-
ware evaluation. A significantly higher dB-E was found in
plaques with thin fibrous cap and elevated inflammatory
infiltrate. These histological findings are not directly visible
at CEUS evaluation; but, inflammation and thin fibrous cap
are supposedly involved in the same process of plaque
evolution towards vulnerability, similar to the new vessels
growth. Kockx et al.10 and Moreno et al.27 suggested that
neovascularisation supplies a plaque with leucocytes andFigure 3 CD34 immunostaining of intraplaque microvessels. A)
angiomatoid microvascular pattern.lipoproteins and promotes plaque expansion and vulnera-
bility. Leucocytes subsequently play a direct role with
metalloproteinases and cytokine release in the develop-
ment of the thin fibrous cap.28
The main limitation of our study is the relatively scarce
number of patients enrolled, due to the high volume of
analysis requested by the protocol (CEUS examination,
immunohistochemical and morphological analysis and post-
processing evaluation); however, a meaningful association
was found within the data collected. Another limitation
could be the origin of the ischaemic CT lesions, which may
be due to causes different from the carotid plaque;
however, we feel that in the absence of other recognisable
sources of embolism, the presence of an ipsilateral signifi-
cant carotid plaque can be reasonably considered as the
cause of the lesion. We believe that CEUS, although rela-
tively new and with no actual standardisation for plaque
examination and evaluation, may become a suitable stan-
dard technique for the identification of vulnerable plaques.
The previous studies report different numbers of bolus of
the contrast injection and different periods of image
storing. Plaque contrast enhancement was obtained inSmall, regularly-shaped microvascular pattern; B) Cavernous,
Table 8 “Plaque vulnerability” scores and dB-E values expressed as men and SD. In the present table are also expressed
symptomatic and asymptomatic patients’ data subset.
Vulnerability score N (%) dB-E p value N (%) dB-E p value N (%) dB-E p value
Total patients Symptomatic patients Asymptomatic patients
Score 1 6 (27) 2.5  0.6 0.001 0 (0) e 0.3 6 (40) 2.5  0.6 e
Score 2 10 (45) 4.6  0.8 2 (29) 5.4  0.6 8 (53) 4.5  0.8
Score 3 0 (0) 0 (0) e 0 (0) e
Score 4 3 (14) 7.1  0.5 2 (29) 7.2  0.2 1 (6) 6.8
Score 5 3 (14) 7.6  0.2 3 (42) 7.6  0.2 0 (0) e
Contrast Ultrasonography and Carotid “Vulnerable Plaque” 247many cases by operator semiquantitative evaluation, but
Xiong et al. report a software analysis of plaque dB-
enhancement. Although no data for comparing software
and operator semiquantitative evaluation are presently
available in the literature, the software plaque analysis
performed in our study could become an objective method
to investigate plaque vascularisation at CEUS, which could
help in indication to revascularisation, particularly in
asymptomatic patients.
Conclusion
CEUS with dB-E is a strong indicator of the extent of plaque
neovascularisation, with high correlation with ipsilateral
cerebral ischaemic events (stroke or TIA). This technique
could be therefore used to identify vulnerable plaques
characterised by structural elements with high embolic
potential.
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